Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
youxinding
- Development stage
- Unknown
- Lead developer
- Shanghai Innovative Research Center of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Youxinding is a pharmaceutical drug developed as an oral capsule formulation for the treatment of depression, specifically major depressive disorder (MDD). It has undergone multiple phase 2 clinical trials and is currently being evaluated in phase 3 studies for its efficacy and safety in patients with depression. The drug appears to be based on traditional Chinese medicine principles, but the precise active ingredient(s) or molecular mechanism have not been explicitly disclosed in available sources. Clinical studies have focused on dose-ranging (200mg, 300mg, 400mg) to establish optimal dosing regimens. The primary developer and sponsor of clinical research is the Shanghai Chinese Medicine Innovation Research Center[3][10].
- Brand names
- Youxinding
- Other names
- 优欣定Youxinding capsule
02
Targets
HTR3A (5-hydroxytryptamine receptor 3A)NET (Norepinephrine Transporter)
Beyond the preview
Go deeper on youxinding.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on youxinding.